The global anastomosis devices market was valued at 15.74 Million in 2016 and is expected to continue growing at a higher rate. Factors such as rise in surgical procedures with rising incidences of cardiovascular and GT diseases are likely to contribute to the market growth in the forecast period. Overall, the anastomosis devices market is expected to cross a CAGR of 5.2% in the forecast period.
Surgical
procedures have now turned into a perplexed form for cardiac surgeons right
from the inception of coronary arteries bypass grafts and minimally invasive
techniques. Suture technique for coronary anastomosis is becoming insufficient
to suffice new demands from surgeons hence a need arises for alternative techniques
to perform coronary bypasses. Due to the recent medical advancements,
sutureless devices are based on memory shape metal alloy, synthetic, and
biologic glue combined or non-combined with metallic framework and laser
bonding using organic soldering techniques.
Request Sample Copy of This Market Research @
https://www.millioninsights.com/industry-reports/anastomosis-devices-market/request-sample
Anastomosis
devices are easy to use and reduce the dependency on surgeons, which is the
analytical factor for long-term potency. The key element of sutures is placed
between graft vessels and target and any distortion might result into obstruction
of flow. Therefore, anastomotic devices are made available for minimally
invasive or endoscopic use to reduce the heart operations via limited
incisions. For instance, the heartflo anastomotic device is a
micromechanical-suturing device for coronary artery bypass grafting. However,
an ideal anastomotic method is considered only when compression anastomosis
having no foreign bodies left at anastomotic site.
Anastomosis
devices industry is segmented based on product, application, and geography.
Reusable and disposable categories form the bifurcation for product category in
the market. “Application” segment for anastomosis devices market include
general surgeries, cardiovascular diseases, orthopaedic surgeries, and
ophthalmic surgeries.
Geographical
segmentation for anastomosis devices industry spans North America, Latin
America, Europe, Asia-Pacific, Middle East and Africa. North America
anastomosis devices market is expected to rise at a higher CAGR in the forecast
period due to rising medical assistance for cardiovascular diseases.
Asia-Pacific’s anastomosis devices industry is likely to expand at a staggering
CAGR in the forthcoming period due to rise in young workforce, change in
lifestyle leading to occurrence of chronic as well as acute ailments.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/anastomosis-devices-market
The
key players in the anastomosis devices industry include Medtronic; LivaNova
PLC; MAQUET Holding B.V. & Co. KG., Dextera Surgical Inc., Vitalitec
International Inc., Synovis Micro Companies Alliance Inc., and Ethicon US, LLC.
Market
Segment:
Anastomosis
Devices Product Type Outlook (Revenue, USD Million, 2014 - 2025)
• Disposable
• Reusable
Anastomosis
Devices Application Outlook (Revenue, USD Million, 2014 - 2025)
• Cardiovascular Surgery
• Gastrointestinal Surgery
• Others
Comments
Post a Comment